Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CNTX
GRCE
Add up to 3 more stocks
CNTX
Context Therapeutics Inc.
+2.85%
$0.35+0.01Delayed quote: Oct 6, 2026, 10:20 AM EDT
Market Cap
$31.80M
52W Range
$0.30 - $3.62
GRCE
Grace Therapeutics, Inc.
+1.46%
$2.09+0.03Delayed quote: Oct 6, 2026, 10:14 AM EDT
Market Cap
$34.01M
52W Range
$1.79 - $5.18
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.83 | 0.71 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -120.4% | -44.5% |
| ROA | -99.6% | -42.8% |
| ROIC | -126.8% | -52.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.81 | 11.47 |
| Quick Ratio | 5.81 | 11.47 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.